What is William Blair’s Forecast for Tetra Tech Q4 Earnings?
Equities research analysts at William Blair cut their Q4 2025 earnings per share estimates for Tetra Tech in a research note ...
FY2028 Earnings Estimate for TPST Issued By William Blair
Equities researchers at William Blair issued their FY2028 earnings estimates for Tempest Therapeutics in a research report ...
Acuity Brands Q1 EPS Forecast Increased by William Blair
William Blair boosted their Q1 2026 earnings per share estimates for Acuity Brands in a research report issued on Thursday, ...
William Blair optimistic that Tesla shares will bottom and momentum will rebound
Investing.com -- William Blair remains optimistic on Tesla (NASDAQ: TSLA) despite recent setbacks, forecasting that shares ...
William Blair Has Bearish Forecast for Starbucks Q2 Earnings
Equities research analysts at William Blair reduced their Q2 2025 earnings per share estimates for Starbucks in a report ...
Fintel on MSN6d
William Blair Initiates Coverage of Immunic (IMUX) with Outperform Recommendation
Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...
Fintel on MSN6d
William Blair Initiates Coverage of StoneX Group (SNEX) with Outperform Recommendation
Fintel reports that on March 26, 2025, William Blair initiated coverage of StoneX Group (NasdaqGS:SNEX) with a Outperform ...
What is William Blair’s Forecast for Neurogene Q1 Earnings?
Stock analysts at William Blair issued their Q1 2025 EPS estimates for Neurogene in a research report issued to clients and ...
Fintel on MSN7d
William Blair Downgrades AZEK (AZEK)
Fintel reports that on March 24, 2025, William Blair downgraded their outlook for AZEK (NYSE:AZEK) from Outperform to Market ...
William Blair Keeps Their Hold Rating on Neuronetics (STIM)
William Blair analyst Margaret Kaczor maintained a Hold rating on Neuronetics (STIM – Research Report) today. The company’s shares closed ...
Q1 Earnings Estimate for NTLA Issued By William Blair
Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Intellia Therapeutics in a research report ...
William Blair Estimates StoneX Group Q2 Earnings
Stock analysts at William Blair issued their Q2 2025 earnings estimates for StoneX Group in a research report issued on Wednesday, March 26th. William Blair analyst J. Schmitt forecasts that the ...